PDS Biotech amends USD 6 million promissory note with YA II PN Ltd - PDSB News | RalliesPDS Biotech amends USD 6 million promissory note with YA II PN Ltd
P
PDSB• Promissory note amendment details
- PDS Biotechnology amended a $6 million Promissory Note with YA II PN on Aug. 31, 2026.
- Revision tightens cash sweeps tied to the at-the-market program via weekly remittance notices, with payment due within one business day.
- New term requires 100% of net cash proceeds from any equity or equity-linked financing outside the ATM to redeem the note within five business days.
- Nasdaq listing deficiency cure period under the note extended to 180 days from 75 days.
- Amendment takes effect once the Sept. 14, 2026 installment under the note is paid in full.
•
